Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy-Induced Vomiting and Nausea

NCT00272285 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00272285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy-Induced Vomiting and Nausea
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
March 31, 2008
Enrollment
287 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nausea, vomiting